<?xml version="1.0" encoding="UTF-8"?>
<p id="Par10" class="p">In contrast, our finding that the RPO treatment had double EPA and triple DHA contents in 
 <italic class="italic">longissimus dorsi</italic> muscle tissue in comparison with the control was in line with the results of Wachira 
 <italic class="italic">et al</italic>.
 <sup class="sup">
  <xref ref-type="bibr" rid="CR22" class="xref">22</xref>
 </sup> who reported that feeding fish oil increased the muscle proportion (x100) of EPA from 0·7 to 2·3 and DHA from 0·3 to 0·8. The greatest n-6 to n-3 ratio in SO treatment could be explained by high n-6 PUFA contents of safflower oil (57%) as shown in Table 
 <xref rid="Tab1" ref-type="table" class="xref">1</xref>. According to Pannier, 
 <italic class="italic">et al</italic>.
 <sup class="sup">
  <xref ref-type="bibr" rid="CR24" class="xref">24</xref>
 </sup>, a standard serve was 135 g of meat. Food Standards of Australia and New Zealand (FSANZ) regulate that a given food can be claimed as a ‘source’ of omega-3 fatty acids if the EPA + DHA contents of that food is greater than 30 mg per serve
 <sup class="sup">
  <xref ref-type="bibr" rid="CR25" class="xref">25</xref>
 </sup>. Lambs in the CO, FSO, SO and RPO treatments had EPA + DHA content in the 
 <italic class="italic">longissimus dorsi</italic> muscle exceeding the 30 mg per serve cut-off point for “source” claim under the FSANZ guidelines
 <sup class="sup">
  <xref ref-type="bibr" rid="CR25" class="xref">25</xref>
 </sup> (as depicted in Fig. 
 <xref rid="Fig1" ref-type="fig" class="xref">1</xref>) and the n-6/n-3 ratio within the desirable level of less than 4.0
 <sup class="sup">
  <xref ref-type="bibr" rid="CR26" class="xref">26</xref>
 </sup>. The DPA content is not currently considered as an omega-3 content claim under current regulations
 <sup class="sup">
  <xref ref-type="bibr" rid="CR27" class="xref">27</xref>
 </sup>; however, Australia and New Zealand have guidelines for total EPA + DHA + DPA consumption
 <sup class="sup">
  <xref ref-type="bibr" rid="CR28" class="xref">28</xref>
 </sup>. Byelashov, 
 <italic class="italic">et al</italic>.
 <sup class="sup">
  <xref ref-type="bibr" rid="CR29" class="xref">29</xref>
 </sup> revealed that DPA was related to various improvements in human health and served as a storage depot for EPA and DHA in the human body. Howe, 
 <italic class="italic">et al</italic>.
 <sup class="sup">
  <xref ref-type="bibr" rid="CR27" class="xref">27</xref>
 </sup> suggested that the importance of DPA in delivering the health benefits associated with n-3 LC-PUFA was equal to that of EPA and DHA. Therefore, if DPA was considered as an omega-3 content claim, a significant amount of n-3 LC-PUFA intake (~39%) would be added to lamb meat consumers as demonstrated in Fig. 
 <xref rid="Fig1" ref-type="fig" class="xref">1</xref>.
</p>
